Technology | 2009.09.03
Idera Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors (TLR), today announced that it will discuss its TLR-targeted drug discovery and development programs and provide a general corporate overview at the Rodman & Renshaw Annual Global Investment Conference on Thursday, September 10, 2009, at 2:25 p.m. EDT at the Palace Hotel in New Yor
For more information, please visit
http://www.businesswire.com/news/home/20090903005070/en
